Examining developmental delay following perinatal opioid exposure: a matched cohort analysis

Monday, April 25, 2022

1:45 PM – 2:00 PM US MT

Location: Convention Center: Mile High Ballroom 3AB

CE: Enduring CME: 0.25

Publication Number: 3585.4

Samuel D. Pimentel, University of California, Berkeley, Berkeley, CA, United States; lena Sun, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, United States; Cynthia I. Campbell, Kaiser Permanente Division of Research, Oakland, CA, United States; Sherian Li, Kaiser Permanente, San Ramon, CA, United States; Eileen M. Walsh, Kaiser Permanente Northern California, Oakland, CA, United States; Lisa A. Croen, Kaiser Permanente Division of Research, Oakland, CA, United States; Sandra D. Comer, Columbia Unviersity, New York, NY, United States; Monique Hedderson, Kaiser Permanente Division of Research, Oakland, CA, United States; Michael Kuzniewicz, Kaiser Permanante, Los Gatos, CA, United States

Presenting Author(s)

Samuel D. Pimentel, PhD
Assistant Professor of Statistics
University of California, Berkeley
Berkeley, California, United States

Full Presentation

Participants should be aware of the following financial/non-financial relationships:

Samuel D. Pimentel, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

lena Sun, MD: ● Merck (Currently Ongoing) (Products/Services: Consultant).

Cynthia I. Campbell, PhD, MPH: ● Industry PMR Consortium; companies conducting postmarketing studies required by the FDA to assess risks of opioid analgesic use (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator).

Sherian Li, Master: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Eileen M. Walsh, RN, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Lisa A. Croen, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Sandra D. Comer, PhD: ● Alkermes (Currently Ongoing) (Products/Services: Consultant).
● BioXcel (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator).
● Intra-cellular Therapies (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator).
● Janssen (Ended In the Past 24 Months) (Products/Services: Research Support including clinical trials & the principal or named investigator).
● Lyndra (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator).
● Opiant (Currently Ongoing) (Products/Services: Advisory Committee).

Monique Hedderson, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Michael Kuzniewicz, MD MPH: ● Chiesi USA (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Intellectual Property including patent beneficiary and royalties).